Surveillance AFter Extremity Tumor surgerY
NCT03944798 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310
Last updated 2024-11-22
Summary
Following treatment for a primary extremity sarcoma, patients remain at risk for the development of local and systemic disease recurrence. Metastasis (distant recurrence) to the lung is the most frequent single location of disease recurrence in sarcoma patients, occurring in almost half of all patients. Therefore, careful post-operative surveillance is an integral element of patient care. However, the detection of metastases does not necessarily affect long-term survival and may negatively impact quality of life. Surveillance strategies have not been well researched and have been identified as the top research priority in the extremity sarcoma field. Using a 2X2 factorial design to maximize efficiency and reduce overall trial costs, the SAFETY trial randomized 310 extremity soft-tissue sarcoma (STS) patients to determine the effect of surveillance strategy on overall patient survival after surgery for a STS of the extremity by comparing the effectiveness of both surveillance frequency (every 3 vs. every 6 months) and imaging modality (CT scans vs. chest radiographs).
Conditions
- Soft Tissue Sarcoma
- Lung Metastases
Interventions
- OTHER
-
Frequency: Every 3 Months
every 3 months
- OTHER
-
Frequency: Every 6 Months
every 6 months
- OTHER
-
Imaging Modality: Chest Radiograph (CXR)
Chest radiograph (CXR)
- OTHER
-
Imaging Modality: Chest CT
Chest computed tomography (CT)
Sponsors & Collaborators
-
Hamilton Academic Health Sciences Organization
collaborator OTHER -
Canadian Cancer Society (CCS)
collaborator OTHER -
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
American Academy of Orthopaedic Surgeons
collaborator OTHER -
Musculoskeletal Tumor Society
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Michelle Ghert, MD · McMaster University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-19
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
- Argentina
- Australia
- Austria
- Belgium
- Brazil
- Canada
- Germany
- Italy
- Malaysia
- Netherlands
- Portugal
- Spain
- Sweden
Study Locations
More Related Trials
-
Comparison of Preoperative CT Scan Guided and Intraoperative Hybrid DynaCT Scan-Guided Small Lung Tumor Localization
NCT03395964 ·Status: COMPLETED ·Phase: NA
-
Sequence of Vessel Interruption and Circulating Tumor Cells in Surgical Lung Cancer
NCT03645252 ·Status: UNKNOWN ·Phase: NA
-
Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil
NCT04947683 ·Status: COMPLETED
-
Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer
NCT05740852 ·Status: COMPLETED
-
Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
NCT06526897 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Feasibility of Exercise With Post-Op Lung Cancer Patients
NCT00636571 ·Status: COMPLETED ·Phase: NA
-
Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer
NCT00221169 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Post-Treatment Surveillance in Lung Cancer
NCT03475420 ·Status: COMPLETED
-
Searching for Predictive Biomarkers of Efficacy in Small Cell Lung Cancer Patients Treated With Chemotherapy-immunotherapy Combination Using Imaging Mass Cytometry (HYPE)
NCT06558903 ·Status: ACTIVE_NOT_RECRUITING
-
Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma
NCT00188279 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study
NCT06743555 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up
NCT00198341 ·Status: COMPLETED ·Phase: NA
-
Intraoperative Conversion During Video-assisted Thoracoscopy Resection for Lung Cancer Does Not Alter Survival
NCT04663191 ·Status: COMPLETED
-
Evaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery Patients
NCT06577844 ·Status: RECRUITING ·Phase: NA
-
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06443684 ·Status: RECRUITING
-
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
NCT03413956 ·Status: COMPLETED
-
Evaluation of Tumor Resection and Reconstruction With Prosthetic Implants
NCT07337018 ·Status: NOT_YET_RECRUITING
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer Surgery
NCT03162718 ·Status: COMPLETED ·Phase: NA
-
Prevention of Tumor Spread Due to Lung Cancer Surgery
NCT00341380 ·Status: COMPLETED
-
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
NCT03710616 ·Status: UNKNOWN
-
Physical Activity and Inactivity in Lung Cancer Survivors
NCT00582348 ·Status: COMPLETED
-
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
NCT03918538 ·Status: COMPLETED ·Phase: NA
-
Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
NCT01279408 ·Status: COMPLETED
-
Prospective rAndomized sTudy efficaCy tHree-dimensional rEconstructions Segmentectomy
NCT05716815 ·Status: NOT_YET_RECRUITING ·Phase: NA